
Hybrid Executive Director/Vice President, Clinical Operations
Keros Therapeutics · Lexington, Massachusetts, US, Estados Unidos De América · Hybrid
16 Trabajos a distancia y desde casa en línea
Keros Therapeutics · Lexington, Massachusetts, US, Estados Unidos De América · Hybrid
Keros Therapeutics · Lexington, Massachusetts, US, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Rapidmicrobio · Lexington, Massachusetts, US, Estados Unidos De América · Hybrid
Rapid Micro Biosystems · Lexington, Massachusetts, US, Estados Unidos De América · Hybrid
Anduril industries · Lexington, Massachusetts, Estados Unidos De América · Hybrid
Keros Therapeutics · Lexington, Massachusetts, US, Estados Unidos De América · Hybrid
At Keros, our mission is to deliver significant clinical benefit to a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. With a focus on developing differentiated product candidates that are designed to alter TGF-β signaling, we aim to target the pathways critical for the growth, repair and maintenance of blood cells and a number of tissues, including bone, skeletal muscle, adipose and heart tissue. We believe our product candidates have the potential to unlock the full therapeutic benefits of modulating the TGF-β superfamily and provide disease-modifying benefit to patients.
Job Summary
As Head of Clinical Operations, you will lead the planning and execution strategy of assigned clinical trials to achieve overall program and corporate objectives. You will be responsible for leading a team of clinical managers and clinical trial associates. This person will ensure high quality, feasible trials are planned with clear timelines, within budget and deliverables. They will drive operational excellence through process improvement, sharing best practices, and proactive planning. The Head of Clinical Operations will be the primary point of escalation for resolution of trial management operational issues. This role will interact with the executive committee and is expected to present at development committee meetings and will have direct reports.
Primary Responsibilities
Core Competencies (Required Skills)
Preferred Skills
Education Requirements
Our Diversity, Equity & Inclusion Mission Statement: Keros is an inclusive company. We believe that diversity drives innovation. We continue to build an inclusive culture that encourages, supports, and celebrates the diverse voices of our employees. As such, Keros takes a holistic approach in mentoring, coaching, and developing all of our Keros team members.
Keros Therapeutics is an Equal Opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected veteran status, or any other characteristic protected by applicable federal, state, or local law.
Recruitment & Staffing Agencies:
Keros Therapeutics does not accept unsolicited resumes from any source other than the candidate directly. Any unsolicited submission by an agency to Keros is prohibited. Any resume submitted by an agency without a signed contract or expressed consent by a member of the Keros Therapeutics Human Resources Department, will be considered property of Keros Therapeutics, and no fee shall be owed with respect thereto.